Donor eggs and surrogacy: assessment, screening and preparation

Separate egg source from pregnancy carrying

Donor-egg IVF may be followed by a pregnancy carried by the recipient or by a gestational carrier. Record egg source, sperm source and the person carrying the pregnancy separately. Donation does not automatically mean surrogacy, and family eligibility varies by jurisdiction.

Low AMH alone does not decide egg donation

AMH and AFC mainly inform expected response and egg yield. They do not independently determine egg quality, live birth or ability to carry a pregnancy. Age, history, previous cycles and goals matter; an extremely low AMH result should not alone be used to refuse IVF.[1]

When to discuss donor eggs

Ovarian insufficiency, previous retrieval or embryo-development outcomes, age-related prognosis and maternal genetic risks may prompt a discussion. Compare suitable alternatives, risks, time and costs. Donor eggs do not remove genetic risks from the sperm source or replace genetic counselling.

Name the source and jurisdiction of screening standards

ASRM's 2024 guidance prefers donors aged 21–34. This is a US professional recommendation, not a universal Kyrgyz legal age rule or a promise about every FS partner clinic. Ask the treating institution to explain applicable rules, medical and family history review, infection and genetic screening, counselling and consent.[2]

Have the clinical team interpret screening

Request the screening scope, report dates, risk interpretation and residual-risk explanation that the clinic may lawfully disclose. A normal karyotype or absent family history does not exclude every genetic condition; donor and sperm-source results need joint interpretation. Confirm independent consent, privacy arrangements and responsibility for donation-related care and costs.

Separate treatment planning from PGT-A

The treating team sets stimulation, retrieval, recovery, culture and transfer timing. Next-day recovery and a fixed delivery week should not be promised. The value of routine PGT-A screening is not established; discuss its purpose, available blastocysts, costs and uncertain results before choosing it for a donor-egg cycle.[3]

Record the denominator when comparing outcomes

Ask for the reporting year, sample size, egg source and whether the outcome is pregnancy or live birth. Live birth per transfer differs from cumulative live birth from all embryos from a retrieval. Group data on a webpage do not predict an individual's result.

Confirm documents and responsibilities before contracting

Document gamete source and consent, storage and disposition, payments and cancellation, clinical responsibility, birth registration and destination documents. Contracts do not replace statutory parentage, registration or nationality decisions. Double donation and different marital statuses need separate review. The Kyrgyz ART source is retained for reference; also consult the policy tracker.[4] Historical legal wording review: 2026-08-02. This update is not an individual legal opinion.

Donor-egg preparation questions

Does very low AMH require donor-egg surrogacy?

AMH alone cannot decide this. Age, history, previous treatment and goals inform the egg-source assessment. Ability to carry a pregnancy and any need for a gestational carrier are assessed separately.

What is the donor age standard?

This article cites the ASRM 2024 preference for ages 21–34 in US professional guidance. The treating institution must confirm applicable law, clinic criteria and the individual screening decision.

Is PGT-A mandatory with donor eggs?

It should not be a default requirement for every donor-egg cycle. Discuss purpose, limitations, embryo availability and cost with the clinician; it cannot guarantee live birth.